The agri-biotech industry takes risks by putting in huge money, effort and valuable human resource in conducting research over years to bring innovative technology to the farm. . . .
. . . .
In India, regressive anti-science measures at the behest of certain vested interests are still be the order of day. This is quite clear from India’s recent price control measure for Bt cotton and capping of royalty on GM technology. These [project] . . . India as a country that does not honour technology agreements and intellectual property rights (IPR).
. . . .
The unusual action of the government . . . has a backdrop of a commercial dispute between a few licensees and the technology provider. These measures appear to be in support of a few seed companies who have defaulted on payment of trait fees to the technology provider.
Share this article
. . . .
By interfering in bilateral private agreements between technology providers and licensees, the government is weakening investor . . . confidence. . . . In the larger interest of Indian agriculture and the economy, one would urge the government to reverse these anti-innovation measures.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: POKE ME: GoI must not interfere between GM technology providers and licensees
